119 related articles for article (PubMed ID: 15680433)
1. Evaluation of feline immunodeficiency virus ORF-A mutants as candidate attenuated vaccine.
Pistello M; Bonci F; Isola P; Mazzetti P; Merico A; Zaccaro L; Matteucci D; Bendinelli M
Virology; 2005 Feb; 332(2):676-90. PubMed ID: 15680433
[TBL] [Abstract][Full Text] [Related]
2. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
[TBL] [Abstract][Full Text] [Related]
4. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
Kusuhara H; Hohdatsu T; Okumura M; Sato K; Suzuki Y; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
Vet Microbiol; 2005 Jul; 108(3-4):155-65. PubMed ID: 15899558
[TBL] [Abstract][Full Text] [Related]
5. Should accessory proteins be structural components of lentiviral vaccines? Lessons learned from the accessory ORF-A protein of FIV.
Pistello M
Vet Immunol Immunopathol; 2008 May; 123(1-2):144-9. PubMed ID: 18304653
[TBL] [Abstract][Full Text] [Related]
6. Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus.
Dunham SP; Bruce J; Klein D; Flynn JN; Golder MC; MacDonald S; Jarrett O; Neil JC
Vaccine; 2006 Nov; 24(49-50):7095-108. PubMed ID: 17049683
[TBL] [Abstract][Full Text] [Related]
7. Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18.
Dunham SP; Flynn JN; Rigby MA; Macdonald J; Bruce J; Cannon C; Golder MC; Hanlon L; Harbour DA; Mackay NA; Spibey N; Jarrett O; Neil JC
Vaccine; 2002 Feb; 20(11-12):1483-96. PubMed ID: 11858854
[TBL] [Abstract][Full Text] [Related]
8. Expression of apoptosis-related gene mRNAs in feline T-cells infected with feline immunodeficiency virus (FIV).
Yamazaki J; Hasebe N; Nagafuchi S; Baba K; Tsujimoto H; Kano R; Hasegawa A
Vet Microbiol; 2004 Jun; 101(1):1-8. PubMed ID: 15201028
[TBL] [Abstract][Full Text] [Related]
9. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
[TBL] [Abstract][Full Text] [Related]
10. Vaccination against the feline immunodeficiency virus: the road not taken.
Lecollinet S; Richardson J
Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):167-90. PubMed ID: 17706778
[TBL] [Abstract][Full Text] [Related]
11. Infection of cats by injection with DNA of a feline immunodeficiency virus molecular clone.
Sparger EE; Louie H; Ziomeck AM; Luciw PA
Virology; 1997 Nov; 238(1):157-60. PubMed ID: 9375019
[TBL] [Abstract][Full Text] [Related]
12. Alloimmunity does not protect from challenge with the feline immunodeficiency virus.
Reggeti F; Bienzle D
Vet Immunol Immunopathol; 2008 Jul; 124(1-2):152-62. PubMed ID: 18471896
[TBL] [Abstract][Full Text] [Related]
13. Sequence variation of the feline immunodeficiency virus genome and its clinical relevance.
Stickney AL; Dunowska M; Cave NJ
Vet Rec; 2013 Jun; 172(23):607-14. PubMed ID: 23749359
[TBL] [Abstract][Full Text] [Related]
14. Comparative replication kinetics of two cytopathic feline lentiviruses ex vivo.
Sutton CA; Gordnier PM; Avery RJ; Casey JW
Virology; 2005 Feb; 332(2):519-28. PubMed ID: 15680417
[TBL] [Abstract][Full Text] [Related]
15. Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.
Gupta S; Leutenegger CM; Dean GA; Steckbeck JD; Cole KS; Sparger EE
J Virol; 2007 Jan; 81(2):465-73. PubMed ID: 17079309
[TBL] [Abstract][Full Text] [Related]
16. Molecular subtyping of feline immunodeficiency virus from cats in Melbourne.
Iwata D; Holloway SA
Aust Vet J; 2008 Oct; 86(10):385-9. PubMed ID: 18826508
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA.
Huisman W; Schrauwen EJ; Tijhaar E; Süzer Y; Pas SD; van Amerongen G; Sutter G; Rimmelzwaan GF; Osterhaus AD
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):332-8. PubMed ID: 18952300
[TBL] [Abstract][Full Text] [Related]
18. Intrahost evolution of envelope glycoprotein and OrfA sequences after experimental infection of cats with a molecular clone and a biological isolate of feline immunodeficiency virus.
Huisman W; Schrauwen EJ; Rimmelzwaan GF; Osterhaus AD
Virus Res; 2008 Oct; 137(1):24-32. PubMed ID: 18602181
[TBL] [Abstract][Full Text] [Related]
19. Lessons from the cat: development of vaccines against lentiviruses.
Dunham SP
Vet Immunol Immunopathol; 2006 Jul; 112(1-2):67-77. PubMed ID: 16678276
[TBL] [Abstract][Full Text] [Related]
20. Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS.
Klonjkowski B; Klein D; Galea S; Gavard F; Monteil M; Duarte L; Fournier A; Sayon S; Górna K; Ertl R; Cordonnier N; Sonigo P; Eloit M; Richardson J
Vaccine; 2009 Feb; 27(6):928-39. PubMed ID: 19070641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
